Evaluating the safety of medications during pregnancy and lactation

Journal of Psychosocial Nursing and Mental Health Services

Volumn 47, Issue 3, 2009, Pages 19-22

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST FEEDING; DRUG TOXICITY; FEMALE; HUMAN; MENTAL DISEASE; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

BREAST FEEDING; DRUG TOXICITY; FEMALE; HUMANS; MENTAL DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 66649127059     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20090301-06     Document Type: Article

References (4)

1. Altshuler, L.L., Cohen, L., Szuba, M.P., Burt, V.K., Gitlin, M., & Mintz, J. (1996). Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. American Journal of Psychiatry, 153, 592-606.
2. U.S. Food and Drug Administration. (2005a). Guidance for industry. Clinical lactation studies-Study design, data analysis, and recommendations for labeling. Retrieved January 16, 2009, from http://www.fda.gov/cder/guidance/5918dft.htm
3. U.S. Food and Drug Administration. (2005b). Reviewer guidance. Evaluating the risks of drug exposure in human pregnancies. Retrieved January 16, 2009, from http://www.fda.gov/cder/guidance/6777fnl.htm
4. U.S. Food and Drug Administration. (n.d.). Pregnancy. Retrieved January 16, 2009, from http://www.fda.gov/womens/healthinformation/pregnancy.html